Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
The current Becton Dickinson(BDX) stock price is $207.11, with a market capitalization of 59.02B. The stock trades at a price-to-earnings (P/E) ratio of 35.82 and offers a dividend yield of 2.0%.
On 2026-01-17, Becton Dickinson(BDX) stock moved within a range of $206.78 to $209.12. With shares now at $207.11, the stock is trading +0.2% above its intraday low and -1.0% below the session's peak.
Trading volume for Becton Dickinson(BDX) stock has reached 1.46M, versus its average volume of 1.69M.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
BDX News
Insiders have been trading these 5 stocks: ((MVST)), ((DVLT)), ((RH)), ((BDX)) and ((VSTM)). Here is a breakdown of their recent trades and their value. Claim 7...
New insider activity at Becton Dickinson ( (BDX) ) has taken place on January 16, 2026. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful...
Becton Dickinson (BDX) announced that the FDA has granted 510 clearance for the EnCor EnCompass Breast Biopsy and Tissue Removal System, a multi-modality breast...
Analyst ratings
69%
of 16 ratingsMore BDX News
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $203.90, changing hands for $2...
Advertisement Why BD’s syringe expansion matters for shareholders Becton Dickinson (BDX) is committing US$110 million to expand Neopak Glass Prefillable Syrin...
If you are wondering whether Becton Dickinson is offering fair value at its current share price, you are not alone; many investors are asking the same question....
Becton Dickinson (BDX) announced a $110M investment to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery and su...